[Special Stock] Cellumed, Kakao's Eye-Catching '20 Trillion' Market Highlights Surgical Robot AI Software Advancement

Cellumed is showing strong performance. It appears that its technology related to artificial joints and AI (artificial intelligence) surgical robot software is gaining attention.

As of 9:09 AM on the 3rd, Cellumed is trading at 4,915 KRW, up 12.33% compared to the previous day.

On this day, Cellumed announced that it is preparing to publish papers based on positive clinical results from major university hospitals regarding its self-developed ‘patient-specific implant (PSI)’ for total joint replacement surgery, and is advancing the integration of AI surgical robot software.

According to Cellumed, it recently established a robotic surgery system by integrating its self-developed fixed-type and mobile-type artificial joints with ‘Curexo’s’ artificial joint surgical robot ‘Qubis-Joint.’

Cellumed is conducting research and development on a 3D preoperative artificial joint surgical planning system and third-generation artificial joint surgical robots based on AI and big data in collaboration with ‘Connective.’

Connective has successfully attracted investment from Kakao Ventures. In May, Kakao Ventures decided to focus investments on companies with software and hardware technologies in fields such as digital healthcare, supported by group funding.

Meanwhile, according to market research firm MarketsandMarkets, the global surgical robot market is expected to grow from $6.4 billion (approximately 9.1616 trillion KRW) in 2021 to $14.4 billion (approximately 20.6136 trillion KRW) by 2026.

This content was produced with the assistance of AI translation services.